NCT05649943 2025-09-03APPROACHFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase NA Recruiting566 enrolled
NCT05956639 2023-07-21Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPCThe First Affiliated Hospital with Nanjing Medical UniversityPhase 3 Recruiting100 enrolled